ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
- Long-term debt, 2021
- $676M
- YoY, 2021
- +253.3%
Long-term debt
Long-term debt by fiscal year
| Period | Long-term debt | YoY |
|---|---|---|
| 2021 | $676M | +253.3% |
| 2020 | $191M | — |
Alnylam Pharmaceuticals, Inc.
$219.72−11.46 (−4.96%)Close Oct 2, 2026
| Period | Long-term debt | YoY |
|---|---|---|
| 2021 | $676M | +253.3% |
| 2020 | $191M | — |